CD200 and inflammatory bowel disease: Elshal et al. [115] found that IBD is linked to a disruption in the CD200R1/CD200 axis, where a reduction in DCs that express CD200R1 might play a role in the imbalance between Th17 and regulatory T cells (Treg cells), contributing to the development of IBD.